Are you over 18 and want to see adult content?
More Annotations
A complete backup of https://www.govnokri.in/pwd-maharashtra-tenders/
Are you over 18 and want to see adult content?
A complete backup of https://xhamster3.desi/categories/indian
Are you over 18 and want to see adult content?
A complete backup of https://libros.plus/autores/anne-perry/
Are you over 18 and want to see adult content?
A complete backup of https://bfu-tournaments.com/index.php/news/11285
Are you over 18 and want to see adult content?
A complete backup of https://www.nydailynews.com/
Are you over 18 and want to see adult content?
A complete backup of https://labialove.com/16/model/dominika/
Are you over 18 and want to see adult content?
A complete backup of https://www.creta.gr/company.php?id=30735
Are you over 18 and want to see adult content?
A complete backup of http://lelibros.online/
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of aceboinformatica.blogspot.com
Are you over 18 and want to see adult content?
A complete backup of zazracnekamene.sk
Are you over 18 and want to see adult content?
A complete backup of profvalmirh.blogspot.com
Are you over 18 and want to see adult content?
Text
velocity.
NEWS - BENCHSCI
Feb 4, 2020. BenchSci Raises $22 Million Series B and Launches New AI-Assisted Reagent Selection Product to Optimize $10.2 Billion in Life Science R&D Spend. F-Prime Capital led the round with participation from existing investors including Gradient Ventures,Google’s AI fund.
ABOUT US - THE WORLD LEADER IN AI FOR BIOMEDICAL R&D About Us - The World Leader in AI for Biomedical R&D - BenchSci. At BenchSci, our mission is to exponentially increase the speed and quality of life-saving research. We do so by empowering scientists with the world’s most advanced biomedical artificial intelligence so CAREERS - DO MORE AND MAKE AN IMPACT - BENCHSCI Our mission is to exponentially increase the speed and quality of life-saving research. We do so by empowering scientists with the world’s most advanced biomedical AI so they can run more successful experiments. You want more than a job. You want a career, with professional and personal growth. And to AI-ASSISTED ANTIBODY SELECTION Literature-wide trends on antibody usage across application, species, cell lines, and more. BenchSci is a right step towards a better antibody selection process. Whenever we need antibodies, we start with BenchSci. — Dr. David Rimm, MD, PhD, Professor of Pathology and of Medicine (Medical Oncology); Director Pathology Tissue Services GET STARTED WITH BENCHSCI AT NOVARTIS Use BenchSci at Novartisto run successful experiments with the right reagent. Search by protein target and aliases using comprehensive bioinformatic ontologies. Filter for 19 experimental variables including application, organism, tissue, cell type, cell line, and disease. View published, independent, and vendor figures for 27million reagent
PRINCIPLES OF BLUE NATIVE-PAGE For this week's "Antibody Applications" series, we're delighted to have our first guest writer, Eric Torres, tell us about Blue Native-PAGE.Eric is a PhD Candidate in Biochemistry and Molecular Biology at the University of California, Los Angeles, working in the lab of Dr. Carla Koehler.Take it away Eric! 43 PHARMA COMPANIES USING ARTIFICIAL INTELLIGENCE IN DRUG Simon Smith As Chief Marketing Officer at BenchSci, Simon ensures that people understand the problem we solve, how we solve it, and the value of doing so. Simon also champions our FASTT values—focused advancement with speed, tenacity, and transparency. Outside work, Simon devours books on science, technology, and business, and hacks content, code, and his biology. PRINCIPLES OF DOT BLOTS Dot blot relies on the same principle that many immunological techniques rely on: the recognition and binding of an antigen by an antibody. Briefly, dot blot utilizes a dry nitrocellulose or PVDF membrane that has been "dotted" with sample homogenate (typically a sample volume of ~2uL/dot). The membrane is then blocked for non-specific binding CHROMATIN IMMUNOPRECIPITATION (CHIP) PRINCIPLES AND HOW TO Chromatin immunoprecipitation (ChIP) is a technique that determines whether a protein of interest interacts with a specific DNA sequence. This technique is often used to study the repertoire of sites on DNA that are bound by particular transcription factors or by histone proteins, and to look at the precise genomic locations of varioushistone
AI-ASSISTED REAGENT SELECTION AND EXPERIMENT DESIGN BenchSci is the world leader in AI-Assisted Reagent Selection and Experiment Design. Our preclinical R&D SaaS platform uses machine learning to help pharmaceutical companies increase their researchvelocity.
NEWS - BENCHSCI
Feb 4, 2020. BenchSci Raises $22 Million Series B and Launches New AI-Assisted Reagent Selection Product to Optimize $10.2 Billion in Life Science R&D Spend. F-Prime Capital led the round with participation from existing investors including Gradient Ventures,Google’s AI fund.
ABOUT US - THE WORLD LEADER IN AI FOR BIOMEDICAL R&D About Us - The World Leader in AI for Biomedical R&D - BenchSci. At BenchSci, our mission is to exponentially increase the speed and quality of life-saving research. We do so by empowering scientists with the world’s most advanced biomedical artificial intelligence so CAREERS - DO MORE AND MAKE AN IMPACT - BENCHSCI Our mission is to exponentially increase the speed and quality of life-saving research. We do so by empowering scientists with the world’s most advanced biomedical AI so they can run more successful experiments. You want more than a job. You want a career, with professional and personal growth. And to AI-ASSISTED ANTIBODY SELECTION Literature-wide trends on antibody usage across application, species, cell lines, and more. BenchSci is a right step towards a better antibody selection process. Whenever we need antibodies, we start with BenchSci. — Dr. David Rimm, MD, PhD, Professor of Pathology and of Medicine (Medical Oncology); Director Pathology Tissue Services GET STARTED WITH BENCHSCI AT NOVARTIS Use BenchSci at Novartisto run successful experiments with the right reagent. Search by protein target and aliases using comprehensive bioinformatic ontologies. Filter for 19 experimental variables including application, organism, tissue, cell type, cell line, and disease. View published, independent, and vendor figures for 27million reagent
PRINCIPLES OF BLUE NATIVE-PAGE For this week's "Antibody Applications" series, we're delighted to have our first guest writer, Eric Torres, tell us about Blue Native-PAGE.Eric is a PhD Candidate in Biochemistry and Molecular Biology at the University of California, Los Angeles, working in the lab of Dr. Carla Koehler.Take it away Eric! 43 PHARMA COMPANIES USING ARTIFICIAL INTELLIGENCE IN DRUG Simon Smith As Chief Marketing Officer at BenchSci, Simon ensures that people understand the problem we solve, how we solve it, and the value of doing so. Simon also champions our FASTT values—focused advancement with speed, tenacity, and transparency. Outside work, Simon devours books on science, technology, and business, and hacks content, code, and his biology. PRINCIPLES OF DOT BLOTS Dot blot relies on the same principle that many immunological techniques rely on: the recognition and binding of an antigen by an antibody. Briefly, dot blot utilizes a dry nitrocellulose or PVDF membrane that has been "dotted" with sample homogenate (typically a sample volume of ~2uL/dot). The membrane is then blocked for non-specific binding CHROMATIN IMMUNOPRECIPITATION (CHIP) PRINCIPLES AND HOW TO Chromatin immunoprecipitation (ChIP) is a technique that determines whether a protein of interest interacts with a specific DNA sequence. This technique is often used to study the repertoire of sites on DNA that are bound by particular transcription factors or by histone proteins, and to look at the precise genomic locations of varioushistone
WHAT IS BENCHSCI ANYWAY? BenchSci’s mission is to exponentially increase the speed and quality of life-saving research. We do this by empowering scientists to run more successful experiments with the world's most advanced, easy to use biomedical artificial intelligence software platform. Our technology guides experimental design and accelerates preclinical R&Dfor
ADVISORS BOARD
BenchSci’s Advisory Board is composed of experts in life science research and development and machine learning technology. These advisors provide us with strategicIMPACT ON SCIENCE
I can’t stress enough how easy my antibody search becomes by applying filters I search my protein of interest, filter for the cell line I use and for Western blots, and the output contains loads of images that give me information on what to expect when I perform a GET STARTED WITH BENCHSCI AT NOVARTIS Use BenchSci at Novartisto run successful experiments with the right reagent. Search by protein target and aliases using comprehensive bioinformatic ontologies. Filter for 19 experimental variables including application, organism, tissue, cell type, cell line, and disease. View published, independent, and vendor figures for 27million reagent
AI-ASSISTED REAGENT SELECTION Backed by Google’s AI fund, Gradient Ventures, BenchSci is the industry standard for antibody selection. Over 41,200 scientists in 15 of the top 20 pharmaceutical companies and more than 4,450 academic institutions use BenchSci’s AI-Assisted Antibody Selection to plan more successful experiments, with proven savings of millions per year in hard costs alone. FINDING CLONE ID INFORMATION First, you can search for your clone ID of interest by typing it directly into the search bar (or by using the Clone ID side filter). Figure results will include only antibodies that originated from this clone. On the product results tab, you can similarly browse antibodies that originated from the clone in the search bar. At the top of the CUT&RUN, REAP-SEQ, AND CITE-SEQ, NOW ON BENCHSCI Biomedical research is constantly evolving with new and innovative techniques being developed for drug discovery. To make sure BenchSci continues empowering scientists to find the best reagents for their experiments, we’ve added three new immunoassays to our database: CUT&RUN, REAP-seq, and CITE-seq. Keep reading for more information about these applications, and how you can find 15 INNOVATIVE IMMUNOASSAY TECHNOLOGIES TO HELP YOU CONDUCT New technologies are flipping traditional antibody-based assays on their heads. These immunoassays are quicker, more sensitive, can be conducted high-throughput, and require minimal sample. It’s an exciting time to be a bench scientist! WESTERN BLOT FAIL: 3 (PAINFUL) LESSONS I LEARNED AS A NON Simon Smith As Chief Marketing Officer at BenchSci, Simon ensures that people understand the problem we solve, how we solve it, and the value of doing so. Simon also champions our FASTT values—focused advancement with speed, tenacity, and transparency. Outside work, Simon devours books on science, technology, and business, and hacks content, code, and his biology. CELEBRATING THE INVALUABLE CONTRIBUTIONS OF BLACK In honor of Black History Month, we are taking this opportunity to celebrate some of the significant contributions Black scientists have made to advancing STEM fields. Here, we showcase five influential scientists and their extraordinary achievements. Alice Ball (b. 1892, d. 1916) was a chemist most notable for developing the firstsuccessful
AI-ASSISTED REAGENT SELECTION AND EXPERIMENT DESIGN BenchSci is the world leader in AI-Assisted Reagent Selection and Experiment Design. Our preclinical R&D SaaS platform uses machine learning to help pharmaceutical companies increase their researchvelocity.
NEWS - BENCHSCI
Feb 4, 2020. BenchSci Raises $22 Million Series B and Launches New AI-Assisted Reagent Selection Product to Optimize $10.2 Billion in Life Science R&D Spend. F-Prime Capital led the round with participation from existing investors including Gradient Ventures,Google’s AI fund.
ABOUT US - THE WORLD LEADER IN AI FOR BIOMEDICAL R&D About Us - The World Leader in AI for Biomedical R&D - BenchSci. At BenchSci, our mission is to exponentially increase the speed and quality of life-saving research. We do so by empowering scientists with the world’s most advanced biomedical artificial intelligence soPRICING - BENCHSCI
Enterprise Professional Academic; Workflow integrations including links from intranet and e-procurement tools. Optional. Unnecessary custom reagent order interventions to stop expensive custom orders when commercial equivalents are available. One-click purchasing through integrations with the world’s largest distributors, allowing scientists to order from preferred vendors in one click CAREERS - DO MORE AND MAKE AN IMPACT - BENCHSCI Our mission is to exponentially increase the speed and quality of life-saving research. We do so by empowering scientists with the world’s most advanced biomedical AI so they can run more successful experiments. You want more than a job. You want a career, with professional and personal growth. And to BENCHSCI: GET STARTED—IT'S FREE BenchSci is a reagent intelligence platform that reduces the time, uncertainty, and cost of scientific experiments. We use machine learning to decode comprehensive open- and closed-access datasets, display published figures with no commercial bias, and allow you to search by experimental variables. AI-ASSISTED ANTIBODY SELECTION Literature-wide trends on antibody usage across application, species, cell lines, and more. BenchSci is a right step towards a better antibody selection process. Whenever we need antibodies, we start with BenchSci. — Dr. David Rimm, MD, PhD, Professor of Pathology and of Medicine (Medical Oncology); Director Pathology Tissue Services GET STARTED WITH BENCHSCI AT NOVARTIS Use BenchSci at Novartisto run successful experiments with the right reagent. Search by protein target and aliases using comprehensive bioinformatic ontologies. Filter for 19 experimental variables including application, organism, tissue, cell type, cell line, and disease. View published, independent, and vendor figures for 27million reagent
AI-ASSISTED REAGENT SELECTION Backed by Google’s AI fund, Gradient Ventures, BenchSci is the industry standard for antibody selection. Over 41,200 scientists in 15 of the top 20 pharmaceutical companies and more than 4,450 academic institutions use BenchSci’s AI-Assisted Antibody Selection to plan more successful experiments, with proven savings of millions per year in hard costs alone. PRINCIPLES OF BLUE NATIVE-PAGE For this week's "Antibody Applications" series, we're delighted to have our first guest writer, Eric Torres, tell us about Blue Native-PAGE.Eric is a PhD Candidate in Biochemistry and Molecular Biology at the University of California, Los Angeles, working in the lab of Dr. Carla Koehler.Take it away Eric! AI-ASSISTED REAGENT SELECTION AND EXPERIMENT DESIGN BenchSci is the world leader in AI-Assisted Reagent Selection and Experiment Design. Our preclinical R&D SaaS platform uses machine learning to help pharmaceutical companies increase their researchvelocity.
NEWS - BENCHSCI
Feb 4, 2020. BenchSci Raises $22 Million Series B and Launches New AI-Assisted Reagent Selection Product to Optimize $10.2 Billion in Life Science R&D Spend. F-Prime Capital led the round with participation from existing investors including Gradient Ventures,Google’s AI fund.
ABOUT US - THE WORLD LEADER IN AI FOR BIOMEDICAL R&D About Us - The World Leader in AI for Biomedical R&D - BenchSci. At BenchSci, our mission is to exponentially increase the speed and quality of life-saving research. We do so by empowering scientists with the world’s most advanced biomedical artificial intelligence soPRICING - BENCHSCI
Enterprise Professional Academic; Workflow integrations including links from intranet and e-procurement tools. Optional. Unnecessary custom reagent order interventions to stop expensive custom orders when commercial equivalents are available. One-click purchasing through integrations with the world’s largest distributors, allowing scientists to order from preferred vendors in one click CAREERS - DO MORE AND MAKE AN IMPACT - BENCHSCI Our mission is to exponentially increase the speed and quality of life-saving research. We do so by empowering scientists with the world’s most advanced biomedical AI so they can run more successful experiments. You want more than a job. You want a career, with professional and personal growth. And to BENCHSCI: GET STARTED—IT'S FREE BenchSci is a reagent intelligence platform that reduces the time, uncertainty, and cost of scientific experiments. We use machine learning to decode comprehensive open- and closed-access datasets, display published figures with no commercial bias, and allow you to search by experimental variables. AI-ASSISTED ANTIBODY SELECTION Literature-wide trends on antibody usage across application, species, cell lines, and more. BenchSci is a right step towards a better antibody selection process. Whenever we need antibodies, we start with BenchSci. — Dr. David Rimm, MD, PhD, Professor of Pathology and of Medicine (Medical Oncology); Director Pathology Tissue Services GET STARTED WITH BENCHSCI AT NOVARTIS Use BenchSci at Novartisto run successful experiments with the right reagent. Search by protein target and aliases using comprehensive bioinformatic ontologies. Filter for 19 experimental variables including application, organism, tissue, cell type, cell line, and disease. View published, independent, and vendor figures for 27million reagent
AI-ASSISTED REAGENT SELECTION Backed by Google’s AI fund, Gradient Ventures, BenchSci is the industry standard for antibody selection. Over 41,200 scientists in 15 of the top 20 pharmaceutical companies and more than 4,450 academic institutions use BenchSci’s AI-Assisted Antibody Selection to plan more successful experiments, with proven savings of millions per year in hard costs alone. PRINCIPLES OF BLUE NATIVE-PAGE For this week's "Antibody Applications" series, we're delighted to have our first guest writer, Eric Torres, tell us about Blue Native-PAGE.Eric is a PhD Candidate in Biochemistry and Molecular Biology at the University of California, Los Angeles, working in the lab of Dr. Carla Koehler.Take it away Eric!PRICING - BENCHSCI
Enterprise Professional Academic; Workflow integrations including links from intranet and e-procurement tools. Optional. Unnecessary custom reagent order interventions to stop expensive custom orders when commercial equivalents are available. One-click purchasing through integrations with the world’s largest distributors, allowing scientists to order from preferred vendors in one clickADVISORS BOARD
BenchSci’s Advisory Board is composed of experts in life science research and development and machine learning technology. These advisors provide us with strategic BENCHSCI: GET STARTED—IT'S FREE BenchSci is a reagent intelligence platform that reduces the time, uncertainty, and cost of scientific experiments. We use machine learning to decode comprehensive open- and closed-access datasets, display published figures with no commercial bias, and allow you to search by experimental variables. AI-ASSISTED REAGENT SELECTION Backed by Google’s AI fund, Gradient Ventures, BenchSci is the industry standard for antibody selection. Over 41,200 scientists in 15 of the top 20 pharmaceutical companies and more than 4,450 academic institutions use BenchSci’s AI-Assisted Antibody Selection to plan more successful experiments, with proven savings of millions per year in hard costs alone. DIVERSITY, EQUITY, AND INCLUSION Diversity, equity, and inclusion (DEI) are vital to our success as a company; research shows that more diverse teams outperform less diverse ones. 1 More importantly, social injustice perpetuates a lack of equitable outcomes, resulting in disproportionate barriers to the success of underrepresented groups. 1 David Rock, and Heidi Grant.BENCHSCI BLOG
News and updates from the BenchSci Team on antibody search, reproducibility and more CUT&RUN, REAP-SEQ, AND CITE-SEQ, NOW ON BENCHSCI Biomedical research is constantly evolving with new and innovative techniques being developed for drug discovery. To make sure BenchSci continues empowering scientists to find the best reagents for their experiments, we’ve added three new immunoassays to our database: CUT&RUN, REAP-seq, and CITE-seq. Keep reading for more information about these applications, and how you can find USING X-RAY FILM FOR CHEMILUMINESCENCE WESTERN BLOT: TIPS Continuing from my previous article on western blot detection methods, in this article I will focus the discussion on proper procedures and tips for using X-ray film with chemiluminescence western blotting.. As a reminder from my last post, X-ray film is generally considered to be the most sensitive method for detecting relative protein levels. PRINCIPLES OF DOT BLOTS What is Dot Blot? Dot blot is a simple way to test for the presence of a protein of interest (POI) in a sample. The technique is actually very similar to the Western blot, but dot blot, for reasons we’ll cover later, is a faster, cheaper, and easier technique. WESTERN BLOT FAIL: 3 (PAINFUL) LESSONS I LEARNED AS A NON Simon Smith As Chief Marketing Officer at BenchSci, Simon ensures that people understand the problem we solve, how we solve it, and the value of doing so. Simon also champions our FASTT values—focused advancement with speed, tenacity, and transparency. Outside work, Simon devours books on science, technology, and business, and hacks content, code, and his biology. AI-ASSISTED REAGENT SELECTION AND EXPERIMENT DESIGN BenchSci is the world leader in AI-Assisted Reagent Selection and Experiment Design. Our preclinical R&D SaaS platform uses machine learning to help pharmaceutical companies increase their researchvelocity.
NEWS - BENCHSCI
Feb 4, 2020. BenchSci Raises $22 Million Series B and Launches New AI-Assisted Reagent Selection Product to Optimize $10.2 Billion in Life Science R&D Spend. F-Prime Capital led the round with participation from existing investors including Gradient Ventures,Google’s AI fund.
CAREERS - DO MORE AND MAKE AN IMPACT - BENCHSCI Our mission is to exponentially increase the speed and quality of life-saving research. We do so by empowering scientists with the world’s most advanced biomedical AI so they can run more successful experiments. You want more than a job. You want a career, with professional and personal growth. And to GET STARTED WITH BENCHSCI AT NOVARTIS Use BenchSci at Novartisto run successful experiments with the right reagent. Search by protein target and aliases using comprehensive bioinformatic ontologies. Filter for 19 experimental variables including application, organism, tissue, cell type, cell line, and disease. View published, independent, and vendor figures for 27million reagent
AI-ASSISTED ANTIBODY SELECTION Literature-wide trends on antibody usage across application, species, cell lines, and more. BenchSci is a right step towards a better antibody selection process. Whenever we need antibodies, we start with BenchSci. — Dr. David Rimm, MD, PhD, Professor of Pathology and of Medicine (Medical Oncology); Director Pathology Tissue Services PRINCIPLES OF BLUE NATIVE-PAGE For this week's "Antibody Applications" series, we're delighted to have our first guest writer, Eric Torres, tell us about Blue Native-PAGE.Eric is a PhD Candidate in Biochemistry and Molecular Biology at the University of California, Los Angeles, working in the lab of Dr. Carla Koehler.Take it away Eric! AI-ASSISTED REAGENT SELECTION AND EXPERIMENT DESIGN BenchSci is the world leader in AI-Assisted Reagent Selection and Experiment Design. Our preclinical R&D SaaS platform uses machine learning to help pharmaceutical companies increase their researchvelocity.
NEWS - BENCHSCI
Feb 4, 2020. BenchSci Raises $22 Million Series B and Launches New AI-Assisted Reagent Selection Product to Optimize $10.2 Billion in Life Science R&D Spend. F-Prime Capital led the round with participation from existing investors including Gradient Ventures,Google’s AI fund.
CAREERS - DO MORE AND MAKE AN IMPACT - BENCHSCI Our mission is to exponentially increase the speed and quality of life-saving research. We do so by empowering scientists with the world’s most advanced biomedical AI so they can run more successful experiments. You want more than a job. You want a career, with professional and personal growth. And to GET STARTED WITH BENCHSCI AT NOVARTIS Use BenchSci at Novartisto run successful experiments with the right reagent. Search by protein target and aliases using comprehensive bioinformatic ontologies. Filter for 19 experimental variables including application, organism, tissue, cell type, cell line, and disease. View published, independent, and vendor figures for 27million reagent
AI-ASSISTED ANTIBODY SELECTION Literature-wide trends on antibody usage across application, species, cell lines, and more. BenchSci is a right step towards a better antibody selection process. Whenever we need antibodies, we start with BenchSci. — Dr. David Rimm, MD, PhD, Professor of Pathology and of Medicine (Medical Oncology); Director Pathology Tissue Services PRINCIPLES OF BLUE NATIVE-PAGE For this week's "Antibody Applications" series, we're delighted to have our first guest writer, Eric Torres, tell us about Blue Native-PAGE.Eric is a PhD Candidate in Biochemistry and Molecular Biology at the University of California, Los Angeles, working in the lab of Dr. Carla Koehler.Take it away Eric!ADVISORS BOARD
BenchSci’s Advisory Board is composed of experts in life science research and development and machine learning technology. These advisors provide us with strategic RESOURCES - BENCHSCI Find the resources you need to make the most of BenchSci.PRICING - BENCHSCI
Optional. Unnecessary custom reagent order interventions to stop expensive custom orders when commercial equivalents are available. One-click purchasing through integrations with the world’s largest distributors, allowing scientists to order from preferred vendors in one click within BenchSci. Optional.PARTNERS - BENCHSCI
BenchSci uses AI to augment vendor catalogs. We decode product data from over 10.9 million scientific papers, make it searchable by experimental context, and show published figures of product usage. This helps researchers find and order products faster, with more confidence. Our vendor partners work with us to keep their catalogsup-to-date on
AI-ASSISTED ANTIBODY SELECTION Literature-wide trends on antibody usage across application, species, cell lines, and more. BenchSci is a right step towards a better antibody selection process. Whenever we need antibodies, we start with BenchSci. — Dr. David Rimm, MD, PhD, Professor of Pathology and of Medicine (Medical Oncology); Director Pathology Tissue Services AI-ASSISTED REAGENT SELECTION Backed by Google’s AI fund, Gradient Ventures, BenchSci is the industry standard for antibody selection. Over 41,200 scientists in 15 of the top 20 pharmaceutical companies and more than 4,450 academic institutions use BenchSci’s AI-Assisted Antibody Selection to plan more successful experiments, with proven savings of millions per year in hard costs alone. 43 PHARMA COMPANIES USING ARTIFICIAL INTELLIGENCE IN DRUG Simon Smith As Chief Marketing Officer at BenchSci, Simon ensures that people understand the problem we solve, how we solve it, and the value of doing so. Simon also champions our FASTT values—focused advancement with speed, tenacity, and transparency. Outside work, Simon devours books on science, technology, and business, and hacks content, code, and his biology. CUT&RUN, REAP-SEQ, AND CITE-SEQ, NOW ON BENCHSCI Biomedical research is constantly evolving with new and innovative techniques being developed for drug discovery. To make sure BenchSci continues empowering scientists to find the best reagents for their experiments, we’ve added three new immunoassays to our database: CUT&RUN, REAP-seq, and CITE-seq. Keep reading for more information about these applications, and how you can find 15 INNOVATIVE IMMUNOASSAY TECHNOLOGIES TO HELP YOU CONDUCT New technologies are flipping traditional antibody-based assays on their heads. These immunoassays are quicker, more sensitive, can be conducted high-throughput, and require minimal sample. It’s an exciting time to be a bench scientist! SEVEN WOMEN THAT CHANGED THE WORLD WITH THEIR Harriet Brooks Pitcher (b. 1876, d. 1933) is considered the first Canadian woman nuclear physicist and made significant contributions in the field of atomic physics. She was one of the first to identify the element radon, and to discover the quantum phenomenon of atomic recoil. Ernest Rutherford, considered “the father of nuclear physics AI-ASSISTED REAGENT SELECTION AND EXPERIMENT DESIGN BenchSci is the world leader in AI-Assisted Reagent Selection and Experiment Design. Our preclinical R&D SaaS platform uses machine learning to help pharmaceutical companies increase their researchvelocity.
NEWS - BENCHSCI
Feb 4, 2020. BenchSci Raises $22 Million Series B and Launches New AI-Assisted Reagent Selection Product to Optimize $10.2 Billion in Life Science R&D Spend. F-Prime Capital led the round with participation from existing investors including Gradient Ventures,Google’s AI fund.
ABOUT US - THE WORLD LEADER IN AI FOR BIOMEDICAL R&D About Us - The World Leader in AI for Biomedical R&D - BenchSci. At BenchSci, our mission is to exponentially increase the speed and quality of life-saving research. We do so by empowering scientists with the world’s most advanced biomedical artificial intelligence so CAREERS - DO MORE AND MAKE AN IMPACT - BENCHSCI Our mission is to exponentially increase the speed and quality of life-saving research. We do so by empowering scientists with the world’s most advanced biomedical AI so they can run more successful experiments. You want more than a job. You want a career, with professional and personal growth. And to AI-ASSISTED ANTIBODY SELECTION Literature-wide trends on antibody usage across application, species, cell lines, and more. BenchSci is a right step towards a better antibody selection process. Whenever we need antibodies, we start with BenchSci. — Dr. David Rimm, MD, PhD, Professor of Pathology and of Medicine (Medical Oncology); Director Pathology Tissue Services GET STARTED WITH BENCHSCI AT NOVARTIS Use BenchSci at Novartisto run successful experiments with the right reagent. Search by protein target and aliases using comprehensive bioinformatic ontologies. Filter for 19 experimental variables including application, organism, tissue, cell type, cell line, and disease. View published, independent, and vendor figures for 27million reagent
GET STARTED WITH BENCHSCI AT REAGENT GENIE Reagent Genie scientists have access to BenchSci for AI-Assisted Antibody Selection. Learn how to sign up, log in, and get support. PRINCIPLES OF BLUE NATIVE-PAGE For this week's "Antibody Applications" series, we're delighted to have our first guest writer, Eric Torres, tell us about Blue Native-PAGE.Eric is a PhD Candidate in Biochemistry and Molecular Biology at the University of California, Los Angeles, working in the lab of Dr. Carla Koehler.Take it away Eric! 43 PHARMA COMPANIES USING ARTIFICIAL INTELLIGENCE IN DRUG Simon Smith As Chief Marketing Officer at BenchSci, Simon ensures that people understand the problem we solve, how we solve it, and the value of doing so. Simon also champions our FASTT values—focused advancement with speed, tenacity, and transparency. Outside work, Simon devours books on science, technology, and business, and hacks content, code, and his biology. CHROMATIN IMMUNOPRECIPITATION (CHIP) PRINCIPLES AND HOW TO Chromatin immunoprecipitation (ChIP) is a technique that determines whether a protein of interest interacts with a specific DNA sequence. This technique is often used to study the repertoire of sites on DNA that are bound by particular transcription factors or by histone proteins, and to look at the precise genomic locations of varioushistone
AI-ASSISTED REAGENT SELECTION AND EXPERIMENT DESIGN BenchSci is the world leader in AI-Assisted Reagent Selection and Experiment Design. Our preclinical R&D SaaS platform uses machine learning to help pharmaceutical companies increase their researchvelocity.
NEWS - BENCHSCI
Feb 4, 2020. BenchSci Raises $22 Million Series B and Launches New AI-Assisted Reagent Selection Product to Optimize $10.2 Billion in Life Science R&D Spend. F-Prime Capital led the round with participation from existing investors including Gradient Ventures,Google’s AI fund.
ABOUT US - THE WORLD LEADER IN AI FOR BIOMEDICAL R&D About Us - The World Leader in AI for Biomedical R&D - BenchSci. At BenchSci, our mission is to exponentially increase the speed and quality of life-saving research. We do so by empowering scientists with the world’s most advanced biomedical artificial intelligence so CAREERS - DO MORE AND MAKE AN IMPACT - BENCHSCI Our mission is to exponentially increase the speed and quality of life-saving research. We do so by empowering scientists with the world’s most advanced biomedical AI so they can run more successful experiments. You want more than a job. You want a career, with professional and personal growth. And to AI-ASSISTED ANTIBODY SELECTION Literature-wide trends on antibody usage across application, species, cell lines, and more. BenchSci is a right step towards a better antibody selection process. Whenever we need antibodies, we start with BenchSci. — Dr. David Rimm, MD, PhD, Professor of Pathology and of Medicine (Medical Oncology); Director Pathology Tissue Services GET STARTED WITH BENCHSCI AT NOVARTIS Use BenchSci at Novartisto run successful experiments with the right reagent. Search by protein target and aliases using comprehensive bioinformatic ontologies. Filter for 19 experimental variables including application, organism, tissue, cell type, cell line, and disease. View published, independent, and vendor figures for 27million reagent
GET STARTED WITH BENCHSCI AT REAGENT GENIE Reagent Genie scientists have access to BenchSci for AI-Assisted Antibody Selection. Learn how to sign up, log in, and get support. PRINCIPLES OF BLUE NATIVE-PAGE For this week's "Antibody Applications" series, we're delighted to have our first guest writer, Eric Torres, tell us about Blue Native-PAGE.Eric is a PhD Candidate in Biochemistry and Molecular Biology at the University of California, Los Angeles, working in the lab of Dr. Carla Koehler.Take it away Eric! 43 PHARMA COMPANIES USING ARTIFICIAL INTELLIGENCE IN DRUG Simon Smith As Chief Marketing Officer at BenchSci, Simon ensures that people understand the problem we solve, how we solve it, and the value of doing so. Simon also champions our FASTT values—focused advancement with speed, tenacity, and transparency. Outside work, Simon devours books on science, technology, and business, and hacks content, code, and his biology. CHROMATIN IMMUNOPRECIPITATION (CHIP) PRINCIPLES AND HOW TO Chromatin immunoprecipitation (ChIP) is a technique that determines whether a protein of interest interacts with a specific DNA sequence. This technique is often used to study the repertoire of sites on DNA that are bound by particular transcription factors or by histone proteins, and to look at the precise genomic locations of varioushistone
ADVISORS BOARD
BenchSci’s Advisory Board is composed of experts in life science research and development and machine learning technology. These advisors provide us with strategic RESOURCES - BENCHSCI Find the resources you need to make the most of BenchSci.PRICING - BENCHSCI
Optional. Unnecessary custom reagent order interventions to stop expensive custom orders when commercial equivalents are available. One-click purchasing through integrations with the world’s largest distributors, allowing scientists to order from preferred vendors in one click within BenchSci. Optional.PARTNERS - BENCHSCI
BenchSci uses AI to augment vendor catalogs. We decode product data from over 10.9 million scientific papers, make it searchable by experimental context, and show published figures of product usage. This helps researchers find and order products faster, with more confidence. Our vendor partners work with us to keep their catalogsup-to-date on
AI-ASSISTED ANTIBODY SELECTION Literature-wide trends on antibody usage across application, species, cell lines, and more. BenchSci is a right step towards a better antibody selection process. Whenever we need antibodies, we start with BenchSci. — Dr. David Rimm, MD, PhD, Professor of Pathology and of Medicine (Medical Oncology); Director Pathology Tissue ServicesBENCHSCI BLOG
15 Innovative Immunoassay Technologies to Help You Conduct Your Experiments Faster, High-throughput, with Less Sample, and Get BetterResults
BENCHSCI BLOG
News and updates from the BenchSci Team on antibody search, reproducibility and more FINDING CLONE ID INFORMATION First, you can search for your clone ID of interest by typing it directly into the search bar (or by using the Clone ID side filter). Figure results will include only antibodies that originated from this clone. On the product results tab, you can similarly browse antibodies that originated from the clone in the search bar. At the top of the CUT&RUN, REAP-SEQ, AND CITE-SEQ, NOW ON BENCHSCI Biomedical research is constantly evolving with new and innovative techniques being developed for drug discovery. To make sure BenchSci continues empowering scientists to find the best reagents for their experiments, we’ve added three new immunoassays to our database: CUT&RUN, REAP-seq, and CITE-seq. Keep reading for more information about these applications, and how you can find PRINCIPLES OF DOT BLOTS What is Dot Blot? Dot blot is a simple way to test for the presence of a protein of interest (POI) in a sample. The technique is actually very similar to the Western blot, but dot blot, for reasons we’ll cover later, is a faster, cheaper, and easier technique. AI-ASSISTED REAGENT SELECTION AND EXPERIMENT DESIGN BenchSci is the world leader in AI-Assisted Reagent Selection and Experiment Design. Our preclinical R&D SaaS platform uses machine learning to help pharmaceutical companies increase their researchvelocity.
NEWS - BENCHSCI
Feb 4, 2020. BenchSci Raises $22 Million Series B and Launches New AI-Assisted Reagent Selection Product to Optimize $10.2 Billion in Life Science R&D Spend. F-Prime Capital led the round with participation from existing investors including Gradient Ventures,Google’s AI fund.
ABOUT US - THE WORLD LEADER IN AI FOR BIOMEDICAL R&DAI BASED DRUG DISCOVERYAI DRUG DISCOVERY COMPANIESAI IN DRUG DESIGNBENCHSCI AI About Us - The World Leader in AI for Biomedical R&D - BenchSci. At BenchSci, our mission is to exponentially increase the speed and quality of life-saving research. We do so by empowering scientists with the world’s most advanced biomedical artificial intelligence so CAREERS - DO MORE AND MAKE AN IMPACT - BENCHSCI Our mission is to exponentially increase the speed and quality of life-saving research. We do so by empowering scientists with the world’s most advanced biomedical AI so they can run more successful experiments. You want more than a job. You want a career, with professional and personal growth. And to AI-ASSISTED ANTIBODY SELECTION Literature-wide trends on antibody usage across application, species, cell lines, and more. BenchSci is a right step towards a better antibody selection process. Whenever we need antibodies, we start with BenchSci. — Dr. David Rimm, MD, PhD, Professor of Pathology and of Medicine (Medical Oncology); Director Pathology Tissue Services GET STARTED WITH BENCHSCI AT NOVARTIS Use BenchSci at Novartisto run successful experiments with the right reagent. Search by protein target and aliases using comprehensive bioinformatic ontologies. Filter for 19 experimental variables including application, organism, tissue, cell type, cell line, and disease. View published, independent, and vendor figures for 27million reagent
GET STARTED WITH BENCHSCI AT REAGENT GENIE Reagent Genie scientists have access to BenchSci for AI-Assisted Antibody Selection. Learn how to sign up, log in, and get support. PRINCIPLES OF BLUE NATIVE-PAGE For this week's "Antibody Applications" series, we're delighted to have our first guest writer, Eric Torres, tell us about Blue Native-PAGE.Eric is a PhD Candidate in Biochemistry and Molecular Biology at the University of California, Los Angeles, working in the lab of Dr. Carla Koehler.Take it away Eric! 43 PHARMA COMPANIES USING ARTIFICIAL INTELLIGENCE IN DRUG Simon Smith As Chief Marketing Officer at BenchSci, Simon ensures that people understand the problem we solve, how we solve it, and the value of doing so. Simon also champions our FASTT values—focused advancement with speed, tenacity, and transparency. Outside work, Simon devours books on science, technology, and business, and hacks content, code, and his biology. CHROMATIN IMMUNOPRECIPITATION (CHIP) PRINCIPLES AND HOW TO Chromatin immunoprecipitation (ChIP) is a technique that determines whether a protein of interest interacts with a specific DNA sequence. This technique is often used to study the repertoire of sites on DNA that are bound by particular transcription factors or by histone proteins, and to look at the precise genomic locations of varioushistone
AI-ASSISTED REAGENT SELECTION AND EXPERIMENT DESIGN BenchSci is the world leader in AI-Assisted Reagent Selection and Experiment Design. Our preclinical R&D SaaS platform uses machine learning to help pharmaceutical companies increase their researchvelocity.
NEWS - BENCHSCI
Feb 4, 2020. BenchSci Raises $22 Million Series B and Launches New AI-Assisted Reagent Selection Product to Optimize $10.2 Billion in Life Science R&D Spend. F-Prime Capital led the round with participation from existing investors including Gradient Ventures,Google’s AI fund.
ABOUT US - THE WORLD LEADER IN AI FOR BIOMEDICAL R&DAI BASED DRUG DISCOVERYAI DRUG DISCOVERY COMPANIESAI IN DRUG DESIGNBENCHSCI AI About Us - The World Leader in AI for Biomedical R&D - BenchSci. At BenchSci, our mission is to exponentially increase the speed and quality of life-saving research. We do so by empowering scientists with the world’s most advanced biomedical artificial intelligence so CAREERS - DO MORE AND MAKE AN IMPACT - BENCHSCI Our mission is to exponentially increase the speed and quality of life-saving research. We do so by empowering scientists with the world’s most advanced biomedical AI so they can run more successful experiments. You want more than a job. You want a career, with professional and personal growth. And to AI-ASSISTED ANTIBODY SELECTION Literature-wide trends on antibody usage across application, species, cell lines, and more. BenchSci is a right step towards a better antibody selection process. Whenever we need antibodies, we start with BenchSci. — Dr. David Rimm, MD, PhD, Professor of Pathology and of Medicine (Medical Oncology); Director Pathology Tissue Services GET STARTED WITH BENCHSCI AT NOVARTIS Use BenchSci at Novartisto run successful experiments with the right reagent. Search by protein target and aliases using comprehensive bioinformatic ontologies. Filter for 19 experimental variables including application, organism, tissue, cell type, cell line, and disease. View published, independent, and vendor figures for 27million reagent
GET STARTED WITH BENCHSCI AT REAGENT GENIE Reagent Genie scientists have access to BenchSci for AI-Assisted Antibody Selection. Learn how to sign up, log in, and get support. PRINCIPLES OF BLUE NATIVE-PAGE For this week's "Antibody Applications" series, we're delighted to have our first guest writer, Eric Torres, tell us about Blue Native-PAGE.Eric is a PhD Candidate in Biochemistry and Molecular Biology at the University of California, Los Angeles, working in the lab of Dr. Carla Koehler.Take it away Eric! 43 PHARMA COMPANIES USING ARTIFICIAL INTELLIGENCE IN DRUG Simon Smith As Chief Marketing Officer at BenchSci, Simon ensures that people understand the problem we solve, how we solve it, and the value of doing so. Simon also champions our FASTT values—focused advancement with speed, tenacity, and transparency. Outside work, Simon devours books on science, technology, and business, and hacks content, code, and his biology. CHROMATIN IMMUNOPRECIPITATION (CHIP) PRINCIPLES AND HOW TO Chromatin immunoprecipitation (ChIP) is a technique that determines whether a protein of interest interacts with a specific DNA sequence. This technique is often used to study the repertoire of sites on DNA that are bound by particular transcription factors or by histone proteins, and to look at the precise genomic locations of varioushistone
ADVISORS BOARD
BenchSci’s Advisory Board is composed of experts in life science research and development and machine learning technology. These advisors provide us with strategic RESOURCES - BENCHSCI Find the resources you need to make the most of BenchSci.PRICING - BENCHSCI
Optional. Unnecessary custom reagent order interventions to stop expensive custom orders when commercial equivalents are available. One-click purchasing through integrations with the world’s largest distributors, allowing scientists to order from preferred vendors in one click within BenchSci. Optional.PARTNERS - BENCHSCI
BenchSci uses AI to augment vendor catalogs. We decode product data from over 10.9 million scientific papers, make it searchable by experimental context, and show published figures of product usage. This helps researchers find and order products faster, with more confidence. Our vendor partners work with us to keep their catalogsup-to-date on
AI-ASSISTED ANTIBODY SELECTION Literature-wide trends on antibody usage across application, species, cell lines, and more. BenchSci is a right step towards a better antibody selection process. Whenever we need antibodies, we start with BenchSci. — Dr. David Rimm, MD, PhD, Professor of Pathology and of Medicine (Medical Oncology); Director Pathology Tissue ServicesBENCHSCI BLOG
15 Innovative Immunoassay Technologies to Help You Conduct Your Experiments Faster, High-throughput, with Less Sample, and Get BetterResults
BENCHSCI BLOG
News and updates from the BenchSci Team on antibody search, reproducibility and more FINDING CLONE ID INFORMATION First, you can search for your clone ID of interest by typing it directly into the search bar (or by using the Clone ID side filter). Figure results will include only antibodies that originated from this clone. On the product results tab, you can similarly browse antibodies that originated from the clone in the search bar. At the top of the CUT&RUN, REAP-SEQ, AND CITE-SEQ, NOW ON BENCHSCI Biomedical research is constantly evolving with new and innovative techniques being developed for drug discovery. To make sure BenchSci continues empowering scientists to find the best reagents for their experiments, we’ve added three new immunoassays to our database: CUT&RUN, REAP-seq, and CITE-seq. Keep reading for more information about these applications, and how you can find PRINCIPLES OF DOT BLOTS What is Dot Blot? Dot blot is a simple way to test for the presence of a protein of interest (POI) in a sample. The technique is actually very similar to the Western blot, but dot blot, for reasons we’ll cover later, is a faster, cheaper, and easier technique. AI-ASSISTED REAGENT SELECTION AND EXPERIMENT DESIGN BenchSci is the world leader in AI-Assisted Reagent Selection and Experiment Design. Our preclinical R&D SaaS platform uses machine learning to help pharmaceutical companies increase their researchvelocity.
NEWS - BENCHSCI
Feb 4, 2020. BenchSci Raises $22 Million Series B and Launches New AI-Assisted Reagent Selection Product to Optimize $10.2 Billion in Life Science R&D Spend. F-Prime Capital led the round with participation from existing investors including Gradient Ventures,Google’s AI fund.
ABOUT US - THE WORLD LEADER IN AI FOR BIOMEDICAL R&DAI BASED DRUG DISCOVERYAI DRUG DISCOVERY COMPANIESAI IN DRUG DESIGNBENCHSCI AI About Us - The World Leader in AI for Biomedical R&D - BenchSci. At BenchSci, our mission is to exponentially increase the speed and quality of life-saving research. We do so by empowering scientists with the world’s most advanced biomedical artificial intelligence so CAREERS - DO MORE AND MAKE AN IMPACT - BENCHSCI Our mission is to exponentially increase the speed and quality of life-saving research. We do so by empowering scientists with the world’s most advanced biomedical AI so they can run more successful experiments. You want more than a job. You want a career, with professional and personal growth. And to AI-ASSISTED ANTIBODY SELECTION Literature-wide trends on antibody usage across application, species, cell lines, and more. BenchSci is a right step towards a better antibody selection process. Whenever we need antibodies, we start with BenchSci. — Dr. David Rimm, MD, PhD, Professor of Pathology and of Medicine (Medical Oncology); Director Pathology Tissue Services GET STARTED WITH BENCHSCI AT NOVARTIS Use BenchSci at Novartisto run successful experiments with the right reagent. Search by protein target and aliases using comprehensive bioinformatic ontologies. Filter for 19 experimental variables including application, organism, tissue, cell type, cell line, and disease. View published, independent, and vendor figures for 27million reagent
GET STARTED WITH BENCHSCI AT REAGENT GENIE Reagent Genie scientists have access to BenchSci for AI-Assisted Antibody Selection. Learn how to sign up, log in, and get support. PRINCIPLES OF BLUE NATIVE-PAGE For this week's "Antibody Applications" series, we're delighted to have our first guest writer, Eric Torres, tell us about Blue Native-PAGE.Eric is a PhD Candidate in Biochemistry and Molecular Biology at the University of California, Los Angeles, working in the lab of Dr. Carla Koehler.Take it away Eric! 43 PHARMA COMPANIES USING ARTIFICIAL INTELLIGENCE IN DRUG Simon Smith As Chief Marketing Officer at BenchSci, Simon ensures that people understand the problem we solve, how we solve it, and the value of doing so. Simon also champions our FASTT values—focused advancement with speed, tenacity, and transparency. Outside work, Simon devours books on science, technology, and business, and hacks content, code, and his biology. CHROMATIN IMMUNOPRECIPITATION (CHIP) PRINCIPLES AND HOW TO Chromatin immunoprecipitation (ChIP) is a technique that determines whether a protein of interest interacts with a specific DNA sequence. This technique is often used to study the repertoire of sites on DNA that are bound by particular transcription factors or by histone proteins, and to look at the precise genomic locations of varioushistone
AI-ASSISTED REAGENT SELECTION AND EXPERIMENT DESIGN BenchSci is the world leader in AI-Assisted Reagent Selection and Experiment Design. Our preclinical R&D SaaS platform uses machine learning to help pharmaceutical companies increase their researchvelocity.
NEWS - BENCHSCI
Feb 4, 2020. BenchSci Raises $22 Million Series B and Launches New AI-Assisted Reagent Selection Product to Optimize $10.2 Billion in Life Science R&D Spend. F-Prime Capital led the round with participation from existing investors including Gradient Ventures,Google’s AI fund.
ABOUT US - THE WORLD LEADER IN AI FOR BIOMEDICAL R&DAI BASED DRUG DISCOVERYAI DRUG DISCOVERY COMPANIESAI IN DRUG DESIGNBENCHSCI AI About Us - The World Leader in AI for Biomedical R&D - BenchSci. At BenchSci, our mission is to exponentially increase the speed and quality of life-saving research. We do so by empowering scientists with the world’s most advanced biomedical artificial intelligence so CAREERS - DO MORE AND MAKE AN IMPACT - BENCHSCI Our mission is to exponentially increase the speed and quality of life-saving research. We do so by empowering scientists with the world’s most advanced biomedical AI so they can run more successful experiments. You want more than a job. You want a career, with professional and personal growth. And to AI-ASSISTED ANTIBODY SELECTION Literature-wide trends on antibody usage across application, species, cell lines, and more. BenchSci is a right step towards a better antibody selection process. Whenever we need antibodies, we start with BenchSci. — Dr. David Rimm, MD, PhD, Professor of Pathology and of Medicine (Medical Oncology); Director Pathology Tissue Services GET STARTED WITH BENCHSCI AT NOVARTIS Use BenchSci at Novartisto run successful experiments with the right reagent. Search by protein target and aliases using comprehensive bioinformatic ontologies. Filter for 19 experimental variables including application, organism, tissue, cell type, cell line, and disease. View published, independent, and vendor figures for 27million reagent
GET STARTED WITH BENCHSCI AT REAGENT GENIE Reagent Genie scientists have access to BenchSci for AI-Assisted Antibody Selection. Learn how to sign up, log in, and get support. PRINCIPLES OF BLUE NATIVE-PAGE For this week's "Antibody Applications" series, we're delighted to have our first guest writer, Eric Torres, tell us about Blue Native-PAGE.Eric is a PhD Candidate in Biochemistry and Molecular Biology at the University of California, Los Angeles, working in the lab of Dr. Carla Koehler.Take it away Eric! 43 PHARMA COMPANIES USING ARTIFICIAL INTELLIGENCE IN DRUG Simon Smith As Chief Marketing Officer at BenchSci, Simon ensures that people understand the problem we solve, how we solve it, and the value of doing so. Simon also champions our FASTT values—focused advancement with speed, tenacity, and transparency. Outside work, Simon devours books on science, technology, and business, and hacks content, code, and his biology. CHROMATIN IMMUNOPRECIPITATION (CHIP) PRINCIPLES AND HOW TO Chromatin immunoprecipitation (ChIP) is a technique that determines whether a protein of interest interacts with a specific DNA sequence. This technique is often used to study the repertoire of sites on DNA that are bound by particular transcription factors or by histone proteins, and to look at the precise genomic locations of varioushistone
ADVISORS BOARD
BenchSci’s Advisory Board is composed of experts in life science research and development and machine learning technology. These advisors provide us with strategic RESOURCES - BENCHSCI Find the resources you need to make the most of BenchSci.PRICING - BENCHSCI
Optional. Unnecessary custom reagent order interventions to stop expensive custom orders when commercial equivalents are available. One-click purchasing through integrations with the world’s largest distributors, allowing scientists to order from preferred vendors in one click within BenchSci. Optional.PARTNERS - BENCHSCI
BenchSci uses AI to augment vendor catalogs. We decode product data from over 10.9 million scientific papers, make it searchable by experimental context, and show published figures of product usage. This helps researchers find and order products faster, with more confidence. Our vendor partners work with us to keep their catalogsup-to-date on
AI-ASSISTED ANTIBODY SELECTION Literature-wide trends on antibody usage across application, species, cell lines, and more. BenchSci is a right step towards a better antibody selection process. Whenever we need antibodies, we start with BenchSci. — Dr. David Rimm, MD, PhD, Professor of Pathology and of Medicine (Medical Oncology); Director Pathology Tissue ServicesBENCHSCI BLOG
15 Innovative Immunoassay Technologies to Help You Conduct Your Experiments Faster, High-throughput, with Less Sample, and Get BetterResults
BENCHSCI BLOG
News and updates from the BenchSci Team on antibody search, reproducibility and more FINDING CLONE ID INFORMATION First, you can search for your clone ID of interest by typing it directly into the search bar (or by using the Clone ID side filter). Figure results will include only antibodies that originated from this clone. On the product results tab, you can similarly browse antibodies that originated from the clone in the search bar. At the top of the CUT&RUN, REAP-SEQ, AND CITE-SEQ, NOW ON BENCHSCI Biomedical research is constantly evolving with new and innovative techniques being developed for drug discovery. To make sure BenchSci continues empowering scientists to find the best reagents for their experiments, we’ve added three new immunoassays to our database: CUT&RUN, REAP-seq, and CITE-seq. Keep reading for more information about these applications, and how you can find PRINCIPLES OF DOT BLOTS What is Dot Blot? Dot blot is a simple way to test for the presence of a protein of interest (POI) in a sample. The technique is actually very similar to the Western blot, but dot blot, for reasons we’ll cover later, is a faster, cheaper, and easier technique. We use cookies on our website to make your browsing experience better. By using the site, you agree to use our cookies. Learn moreAccept
* Applications
* AI-Assisted Reagent Selection * AI-Assisted Antibody Selection* Platform Updates
* Customers
* Pricing
* Resources
* Blog
* Customer Impact
* Avoidable Experiment Expenditure* Experts
* Help Center
* Company
* About Us
* Careers
* News
* Partners
* BenchSci Forward
* Impact on Science
* Diversity, Equity, and Inclusion* Academics
* Log In
* Sign Up
* Applications
* AI-Assisted Reagent Selection * AI-Assisted Antibody Selection* Platform Updates
* Customers
* Pricing
* Resources
* Blog
* Customer Impact
* Avoidable Experiment Expenditure* Experts
* Help Center
* Company
* About Us
* Careers
* News
* Partners
* BenchSci Forward
* Impact on Science
* Diversity, Equity, and Inclusion* Academics
GO FROM TARGET TO TRIAL IN A FRACTION OF THE TIME BenchSci empowers scientists with the world’s most advanced biomedical AI to advance assets with fewer, more successfulexperiments
Learn More
135 particles
EXPERIMENTS ARE THE LIFEBLOOD OF R&D, YET MOST FAIL TO ADVANCE THE STUDY OF DRUGS AND TARGETS Reasons for this include:Redundancy
Unusable results
Irreproducibility
REDUNDANCY
Many experiments are unnecessary duplicates due to a lack of visibility into prior experiments.UNUSABLE RESULTS
Other experiments may fail to produce useful data, for example, if a suboptimal antibody fails to detect the presence of a protein.IRREPRODUCIBILITY
Even when an experiment seemingly succeeds, scientists are often unable to replicate the results due to various factors. It isn’t scientists’ fault this happens; they simply don’t have reliable access to the information that would enable them to prevent it. That’s where BenchSci comes in. BENCHSCI RETURNS TIME TO SCIENTISTS AND INCREASES RESEARCH VELOCITY We exponentially increase the speed and quality of life-saving research by empowering scientists with the world’s most advanced biomedical artificial intelligence to run more successful experiments. USING MACHINE LEARNING, BENCHSCI PUTS THE WORLD’S BIOMEDICAL KNOWLEDGE AT SCIENTISTS' FINGERTIPS1 - CURATE
2 - DECODE
3 - PRESENT
CURATE
Curate the world's largest collection of data from life science experiments and reagent catalogsDECODE
Decode and organize the information with proprietary machine learningmodels
PRESENT
Provide rapid insights in a clear, easy-to-use interface with turnkey deployment across an enterpriseCURATE
Curate the world's largest collection of data from life science experiments and reagent catalogsDECODE
Decode and organize the information with reagent-specific machinelearning models
PRESENT
Provide rapid insights in a clear, easy-to-use interface with turnkey deployment across an enterprise* 1
* 2
* 3
* 1
* 2
* 3
* 4
* 5
* 6
OUR POWERFUL TECHNOLOGY IS EXCEPTIONALLY INTUITIVERequest a Demo
BENCHSCI IS THE WORLD LEADER IN AI-ASSISTED EXPERIMENT DESIGN 15 top 20 pharma companies trust BenchSci, along with more than 41,200 scientists working at more than 4,450 institutions worldwide Companies using BenchSci save millions per year in hard costs alone** ** Based on proprietary customer spend analysis. Depends on a number of factors, including a company’s total annual reagent spend and itswaste ratio.
If we had BenchSci we would have saved 3 months on our project — Scientist at top 15 pharma company Researchers using BenchSci move faster, with less time searching for and validating reagents Over 80% of scientists say that BenchSci accelerates their work^ ^ On average from surveys conducted on hundreds of industry scientists across various therapeutic areas and geographies. In partnership with the world's leading scientific publishers Proudly funded by F-Prime, Gradient Ventures (Google’s AI fund), andInovia Capital
INCREASE EXPERIMENTAL SUCCESS AND RESEARCH VELOCITY WITH BENCHSCILearn More
Already have an account? Click hereto log-in.
* Applications
* AI-Assisted
Reagent Selection
* AI-Assisted
Antibody Selection
* Platform Updates
* Company
* About Us
* Careers
* Leadership
Principles
* News
* Partners
* BenchSci Forward
* Impact on Science
* Diversity, Equity,and Inclusion
* Resources
* Blog
* Customer Impact
* Avoidable
Experiment
Expenditure
* Experts
* Help Center
* Get Started
* Pricing
* Customers
* Sign Up
* Log In
* Request a Demo
* Legal
* Privacy Policy
* Terms of Use
* Compliance
* Get in Touch
* Contact Us
*
* © 2017-2021 BenchSciDetails
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0